‘COVID-19 Vaccine is Likely to be Available before November 2020’ : President Trump Makes Shocking New Claim!

Medical experts and scientists from across the United States are racing against one another to find a vaccine which can potentially end the global coronavirus pandemic. However, increasing concerns regarding effective testing to measure the safety of the vaccine is causing alarm.
The United States’ President on Thursday announced that there is a possibility of a vaccine emerging before the presidential elections which are to be held on November 3. Hence, he has hinted that a vaccine might be made available by November 2020. When asked if bringing a vaccine will boost the chances of a re-election, Trump replied that “It wouldn’t hurt” and also added that his priority is to “save a lot of lives.”
“The need (for a Coronavirus vaccine) is urgent but all vaccines must be rigorously studied to determine whether their benefits exceeded their risks. For this reason, we urge that Covid-19 vaccines are made widely available only after the Food and Drug Administration (the drug regulator in the United States) has been able to evaluate safety and efficacy data from completed phase-3 clinical trials. The FDA’s review must be as thorough as has been the case for previous vaccine candidates,” read a letter to the FDA by medical experts.
“We must be able to explain to the public what we know and what we don’t know about these vaccines. For that to happen, we must be able to witness a transparent and rigorous FDA approval process that is devoid of political considerations. We ask that company executives and government officials take due note of these key points,” the experts said in the letter.
Speaking of the rush in finding a vaccine, Anthony Fauci, a top infectious diseases expert in the US said, “I am cautiously optimistic, though you can never guarantee things with a vaccine. I am cautiously optimistic that we will have a vaccine that is effective enough to get approved, because the early studies of phase-1 study showed that it induced the kind of neutralising antibodies that were at least comparable, if not better than what you see in convalescent serum. And that is a whole mark of a predictive quality that a vaccine might work.”